Live Feed

Feed to the latest filings at the SEC

 

BARCLAYS BANK PLC

Date Filed : Sep 15, 2023

FWP1dp200114_fwp-5283ms.htmFORM FWP

Barclays Bank PLC has filed a registrationstatement (including a prospectus) with the U.S. Securities and Exchange Commission (“SEC”) for the offering to which thisfree writing prospectus relates. Before you invest, you should read the prospectus dated May 23, 2022, the prospectus supplement datedJune 27, 2022 and the underlying supplement dated June 27, 2022 and other documents Barclays Bank PLC has filed with the SEC for morecomplete information about Barclays Bank PLC and this offering. You may get these documents and other documents Barclays Bank PLC hasfiled for free by visiting EDGAR on the SEC website at www.sec.gov. Alternatively, Barclays Bank PLC or any agent or dealer participatingin this offering will arrange to send you each of these documents if you request them by calling your Barclays Bank PLC sales representative,such dealer or toll-free 1-888-227-2275 (Extension 2-3430). A copy of each of these documents may be obtained from Barclays Capital Inc.,745 Seventh Avenue—Attn: US InvSol Support, New York, NY 10019.

Free writing prospectus dated September 15, 2023 (to the Prospectus dated May 23, 2022, the Prospectus Supplement dated June 27, 2022 and the Underlying Supplement dated June 27, 2022)

Filed Pursuant to Rule 433

Registration Statement No. 333-265158

 

Summary Terms
Issuer: Barclays Bank PLC
Underlier: ARK Innovation ETF (Bloomberg ticker symbol “ARKK UP <Equity>”)
Pricing date: September 15, 2023. The initial underlier value is the closing price of the underlier on September 14, 2023 and is not the closing price of the underlier on the pricing date.
Original issue date: September 20, 2023
Maturity date: September 18, 2025
Automatic early redemption: If, on any determination date (other than the final determination date), the closing price of the underlier is greater than or equal to the initial underlier value, the securities will be automatically redeemed for an early redemption payment on the contingent payment date immediately following that determination date.
Early redemption payment: An amount per security equal to (i) the stated principal amount plus (ii) the contingent quarterly payment otherwise due
Contingent quarterly payment:

·  If, on any determination date, the closing price of the underlier is greater than or equal to the downside threshold level, we will pay a contingent quarterly payment of $27.50 (2.75% of the stated principal amount) per security on the related contingent payment date.

·  If, on any determination date, the closing price of the underlier is less than the downside threshold level, no contingent quarterly payment will be made with respect to that determination date.

Payment at maturity:

If the securities are not redeemed prior to maturity, you will receive on the maturity date a cash payment per security determined as follows:

·   If the final underlier value is greater than or equal to the downside threshold level:

(i) stated principal amount plus (ii) the contingent quarterly payment otherwise due

·   If the final underlier value is less than the downside threshold level:

stated principal amount × underlier performance factor

Under these circumstances, the payment at maturity will be less than the stated principal amount of $1,000 and will represent a loss of more than 50%, and possibly all, of an investor’s initial investment. Investors may lose their entire initial investment in the securities.

Downside threshold level: $21.805, which is equal to 50% of the initial underlier value (rounded to three decimal places)
Initial underlier value: $43.61, which is the closing price of the underlier on September 14, 2023. The initial underlier value is not the closing price of the underlier on the pricing date.
Final underlier value: The closing price of the underlier on the final determination date
Underlier performance factor: final underlier value/initial underlier value
Determination dates: Quarterly, as specified in the accompanying pricing supplement
Contingent payment dates: Quarterly, as specified in the accompanying pricing supplement
CUSIP/ISIN: 06745NK70 / US06745NK709
Additional terms: Terms used in this document, but not defined herein, will have the meanings ascribed to them in the accompanying pricing supplement.
Pricing supplement: http://www.sec.gov/Archives/edgar/data/312070/000095010323013645/dp200104_424b2-5283ms.htm
Payment on the securities is not guaranteed by any third party and is subject to the creditworthiness of Barclays Bank PLC and the risk of exercise of any U.K. Bail-in Power by the relevant U.K. resolution authority.

Hypothetical Payment at Maturity*
Change in the Underlier Payment at Maturity Total Return on Securities
50.00% $1,000.00 0.00%
40.00% $1,000.00 0.00%
30.00% $1,000.00 0.00%
20.00% $1,000.00 0.00%
10.00% $1,000.00 0.00%
0.00% $1,000.00 0.00%
-5.00% $1,000.00 0.00%
-10.00% $1,000.00 0.00%
-20.00% $1,000.00 0.00%
-30.00% $1,000.00 0.00%
-40.00% $1,000.00 0.00%
-50.00% $1,000.00 0.00%
-50.01% $499.90 -50.01%
-60.00% $400.00 -60.00%
-70.00% $300.00 -70.00%
-80.00% $200.00 -80.00%
-90.00% $100.00 -90.00%
-100.00% $0.00 -100.00%
*The table above assumes the securities are not automatically redeemed prior to maturity and excludes any contingent quarterly payment otherwise due.

Our estimated value of the securities on the pricing date, basedon our internal pricing models, is expected to be between $951.00 and $971.00 per security. The estimated value is expected to be lessthan the initial issue price of the securities. See “Additional Information Regarding Our Estimated Value of the Securities”in the accompanying pricing supplement.

  

 

 

U.K. Bail-in Power Acknowledgment:

Notwithstanding and to the exclusion of any other term of the securitiesor any other agreements, arrangements or understandings between Barclays Bank PLC and any holder or beneficial owner of the securities(or the trustee on behalf of the holders of the securities), by acquiring the securities, each holder and beneficial owner of the securitiesacknowledges, accepts, agrees to be bound by and consents to the exercise of, any U.K. Bail-in Power by the relevant U.K. resolution authority.

The Underlier

For more information about the underlier, including historical performanceinformation, see the accompanying pricing supplement.

Risk Factors

An investment in the securities involves significant risks. Weurge you to consult your investment, legal, tax, accounting and other advisors before you invest in the securities. Some of the risksthat apply to an investment in the securities are summarized below, but we urge you to read the more detailed explanation of risks relatingto the securities generally in the “Risk Factors” sections in the accompanying pricing supplement and the prospectus supplement.You should not purchase the securities unless you understand and can bear the risks of investing in the securities.

Risks Relating to the Securities Generally

·The securities do not guarantee the return of any principal.
·You will not receive any contingent quarterly payment forany quarterly period where the closing price of the underlier on the applicable determination date is less than the downside thresholdlevel.
·You will not participate in any appreciation in the valueof the underlier.
·The securities are subject to early redemption risk.
·Any payment on the securities will be determined based onthe closing prices of the underlier on the dates specified.
·Contingent repayment of principal applies only at maturity.
·The securities are subject to volatilityrisk.
·Investing in the securities is not equivalent to investingin the underlier.
·Significant aspects of the tax treatment of the securitiesare uncertain.

Risks Relating to the Issuer

·Any payments on the securities are subject to issuer creditrisk.
·You may lose some or all of your investment if any U.K. Bail-inPower is exercised by the relevant U.K. resolution authority.

Risks Relating to the Underlier

·Certain features of exchange-traded funds will impact thevalue of the securities.
·Adjustments to the underlier could adversely affect the valueof the securities or result in the securities being accelerated.
·Anti-dilution protection is limited, and the calculationagent has discretion to make anti-dilution adjustments.
·An investment in the securities is subject to risks associatedwith actively managed funds.
·There are risks associated with disruptive innovation companies.

·The securities are subject to risks relating to cryptocurrenciesand related investments.
·The securities are subject to mid-capitalization, small-capitalizationand micro-capitalization companies risks.
·There are risks associated with investments in securitieslinked to the value of non-U.S. equity securities.
·There are risks associated with emerging markets.
·The price of the underlier is subject to currency exchangerisk with respect to the U.S. dollar and the non-U.S. currencies represented in the underlier.
·Governmental legislative or regulatory actions, such as sanctions,could adversely affect your investment in the securities.

Risks Relating to Conflicts of Interest

·Hedging and trading activity by the issuer and its affiliatescould potentially adversely affect the value of the securities.
·We and our affiliates, and any dealer participating in thedistribution of the securities, may engage in various activities or make determinations that could materially affect your securities invarious ways and create conflicts of interest.

Risks Relating to the Estimated Value of the Securities and the SecondaryMarket

·The securities will not be listed on any securities exchange,and secondary trading may be limited.
·The market price of the securities will be influenced bymany unpredictable factors.
·The estimated value of your securities is expected to belower than the initial issue price of your securities.
·The estimated value of your securities might be lower ifsuch estimated value were based on the levels at which our debt securities trade in the secondary market.
·The estimated value of the securities is based on our internalpricing models, which may prove to be inaccurate and may be different from the pricing models of other financial institutions.
·The estimated value of your securities is not a predictionof the prices at which you may sell your securities in the secondary market, if any, and such secondary market prices, if any, will likelybe lower than the initial issue price of your securities and may be lower than the estimated value of your securities.
·The temporary price at which we may initially buy the securitiesin the secondary market and the value we may initially use for customer account statements, if we provide any customer account statementsat all, may not be indicative of future prices of your securities.

Tax Considerations

You should review carefully the section entitled “AdditionalInformation about the Securities—Tax considerations” in the accompanying pricing supplement.

In the event that any of the terms set forth or defined in this documentconflict with the terms or defined terms set forth in the accompanying pricing supplement, the terms or defined terms set forth in theaccompanying pricing supplement will control.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock View